Telehealth practice recommendations for diabetic retinopathy

Telemedicine and e-Health

Volumn 10, Issue 4, 2004, Pages 469-482

  Linkous, Jonathan D ^c   Bakalar, Richard ^c   Darkins, Adam ^c   Poropatich, Ronald K ^c   Cavallerano, Jerry ^a   Lawrence, Mary G ^c   Li, Helen K ^b   Tennant, Matthew ^c   Bursell, Sven ^c   Horton, Mark ^c   Zimmer Galler, Ingrid ^c   Bauman, Wendall ^c   Gardner, W Kelly ^c   Hildebrand, Lloyd ^c   Federman, Jay ^c   Carnahan, Lisa ^c   Kuzmak, Peter ^c   Peters, John M ^c   Ahmed, Jehanara ^c   Aiello, Lloyd M ^c   Aiello, Lloyd P ^c   Buck, Gary ^c   Chen, Ying Ling ^c   Cunningham, Denise ^c   Goodall, Eric ^c   Hope, Ned ^c   Huang, Eugene ^c   Hubbard, Larry ^c   Janczewski, Mark ^c   Lewis, J W L ^c   Matsuzaki, Hiro ^c   McVeigh, Francis L ^c   Motzno, Jordana ^c   Parker Taillon, Diane ^c   Read, Robert ^c   Soliz, Peter ^c   Szirth, Bernard ^c   Vigersky, Robert A ^c   Ward, Thomas ^c   Diver, Catherine ^c   more..

^a JOSLIN DIABETES CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; HEALTH CARE; PATIENT TREATMENT; VISION AIDS;

DIABETIC RETINOPATHY; MEDICAL LITERATURES; OCULAR TELEHEALTH CARE PROGRAM; VISION LOSS;

TELEMEDICINE;

ACCREDITATION; CONSULTATION; DIABETES CONTROL; DIABETIC RETINOPATHY; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH INSURANCE; IMAGE ANALYSIS; IMAGE DISPLAY; INFORMED CONSENT; LICENSING; MEDICAL DOCUMENTATION; MEDICAL ETHICS; PATIENT INFORMATION; PERSONNEL; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TELECOMMUNICATION; UNITED KINGDOM; VITRECTOMY; WORLD HEALTH ORGANIZATION;

EID: 13444256699     PISSN: 15305627     EISSN: None     Source Type: Journal    
DOI: 10.1089/tmj.2004.10.469     Document Type: Review

References (61)

1. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population ages 20-74 yr. Diabetes 1987;36:523-534.
2. Kovar MG, Harris MI, Hadden WC. The scope of diabetes in the United States population. Am J Public Health 1987;77:1549-1550.
3. Harris M. Diabetes Mellitus: Summary. National Institutes of Health, 1995:1-36.
4. World Health Organization. Diabetes estimates and projections. WHO. 2004. Last copyright date: 2003. Accessed at http://www.who.int/ncd/dia/databases4. htm.
5. National Center for Chronic Disease Prevention and Health Promotion. Diabetes Public Health Resource: Age-Adjusted Rates of Seeing a Health Professional for Diabetes in the Last Year per 100 Adults with Diabetes, United States, 2001. Center for Disease control and Prevention. 2001. Accessed at http://www.cdc. gov/diabetes/statistics/preventive/fig4g.htm.
6. Klein R. The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 1987;27: 230-238.
7. Klein R, Klein BE, Moss SE. The Wisconsin Epidemiologcal Study of Diabetic Retinopathy: a review. Diabetes Metab Rev 1989;5:559-570.
8. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-156.
9. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings. DRS Report Number 8. Ophthalmology 1981;88:583-600.
10. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. DRS Report Number 5. Dev Ophthalmol 1981;2:248-261.
11. The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. Arch Ophthalmol 1979;97:654-655.
12. Early Treatment Diabetic Retinopathy Research Group. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. ETDRS Report Number 14. J Am Med Assn 1992;268:1292-1300.
13. Early Treatment Diabetic Retinopathy Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology 1991;98:823-833.
14. Early Treatment Diabetic Retinopathy Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 1991;98: 766-785.
15. Early Treatment Diabetic Retinopathy Research Group. Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch Ophthalmol 1985;103: 1796-1806.
16. Early Treatment Diabetic Retinopathy Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS Report Number 19. Arch Ophthalmol 1995;113:1144-1155.
17. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial. DRVS Report Number 3. Ophthalmology 1988;95:1307-1320.
18. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: DRVS Report Number 5. Arch Ophthalmol 1990;108:958-964.
19. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389.
20. Epidemiology of Diabetes Interventions and Complications Research Group. Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111.
21. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874-886.
22. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. J Am Med Assn 1996;276:1409-1415.
23. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-1298.
24. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-983.
25. The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647-661.
26. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. J Am Med Assn 2002;287: 2563-2569.
27. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 1998;352:837-853.
28. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J 1998;317:703-713.
29. Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. J Am Med Assn 1993;270:1714-1718.
30. Ferris FL, III, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Engl J Med 1999;341:667-678.
31. Witkin SR, Klein R. Ophthalmologic care for persons with diabetes. J Am Med Assn 1984;251:2534-2537.
32. Sprafka JM, Fritsche TL, Baker R, Kurth D, Whipple D. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med 1990;150: 857-861.
33. Javitt JC, Aiello LP, Chiang Y, Ferris FL, III, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994;17:909-917.
34. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164-169.
35. Stanberry B. The legal and ethical aspects of telemedicine 3: telemedicine and malpractice. J Telemed Telecare 1998;2:72-79.
36. Iserson K. Telemedicine: a proposal for an ethical code. Camb Q Healthc Ethics 2000;9:404/6.
37. Mossman K. Medical testing: issues and ethics. Forum Appl Res Public Policy 1997;3:90-101.
38. Silverman R. Current legal and ethical concerns in telemedicine and e-medicine. J Telemed Telecare 2003;9:7-9.
39. Blum J. Internet medicine and the evolving legal status of the physician-patient relationship. J Leg Med 2003;4:413-455.
40. Kasztelowicz P. Security of medical data transfer and storage in Internet Cryptography, antiviral security and electronic signature problems, which must be solved in nearest future in practical contest. Pol J Pathol 2003;3:209-214.
41. Brebner E, Bebner J, Ruddick-Bracken H, Wootton R, Ferguson J. The importance of setting and evaluating standards of telemedicine training. J Telemed Telecare 2003;9:7-9.
42. Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001;108:572-585.
43. Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL. Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology 2002;109:595-601.
44. Rudnisky CJ, Hinz BJ, Tennant MT, de Leon AR, Greve MD. High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology 2002;109:267-274.
45. Lee P. Telemedicine: opportunities and challenges for the remote care of diabetic retinopathy. Arch Ophthalmol 1999;117:1639-1640.
46. Zeimer R, Zou S, Meeder T, et al. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office. Invest Ophthalmol 2002;43:1581-1587.
47. Kuzmak PM, Dayoff RE. Minimizing Digital Imaging and Communications in Medicine (DICOM) Modality Worklist patient/study selection errors. J Digit Imaging 2001;14:153-157.
48. Csipo D, Dayhoff RE, Kuzmak PM. Integrating Digital Imaging and Communications in Medicine (DICOM)-structured reporting into the hospital environment. J Digit Imaging 2001;14:12-16.
49. Bilimoria N. Telemedicine: laws still need a dose of efficiency. J Med Pract Manage 2003;6:289-294.
50. Eliasson A, Poropatich R. Performance improvement in telemedicine: the essential elements. Mil Med 1998; 8:530-535.
51. Comprehensive Accreditation Manual for Hospitals: The Official Handbook. MS.4.120. MS.4.130.: The Joint Commission on the Accredition of Healthcare Oganizations, 2004.
52. Comprehensive Accreditation Manual for Hospitals: The Official Handbook. Improving Organizational Performance: The Joint Commission on the Accreditation of Healthcare Organizations, 2004.
53. Comprehensive Accreditation Manual for Hospitals: The Official Handbook. EC.6.10. EC.6.20. The Joint Commission on the Accreditation of Healthcare Organizations, 2004.
54. Comprehensive Accreditation Manual for Hospitals: The Official Handbook. MS.4.120. MS.4.130.: The Joint Commission on the Accreditation of Healthcare Organizations, 2004.
55. Stanberry B. Legal ethical and risk issues in telemedicine. Comput Methods Programs Biomed 2001,64:225-233.
56. VA. VHA Informed Consent for Clinical Treatments and Procedures: VA, 2003.
57. Wilkinson CP, Ferris FL, 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682.
58. Borkowski W, Mielniczuk H. Telemedical management system of structured clinical documentation-application for quality assurance and multicenter clinical trials. Pol J Pathol 2003;3:193-195.
59. McCrossin R. Managing risk in telemedicine. J Telemed Telecare 2003;9:6-9.
60. Blignault I, Kennedy C. Training for telemedicine. J Telemed Telecare 1999;5(Suppl 1):S112-S114.
61. Comprehensive Accreditation Manual for Hospitals: The Official Handbook. EC6.10. MS.5.10. The Joint Commission on the Accreditation of Healthcare Organizations, 2004.